Mutations in the CCR5 gene and the number of copies of the CCL3L1 gene could play a role in the speed of HIV disease progression and immune responses of healthy individuals, a U.S. study found. The findings could pave the way for modifying HIV drugs and vaccines based on the genetic makeup of a patient, a researcher said.

Full Story:

Related Summaries